Receptor tyrosine kinases are frequently aberrantly hyperactivated in cancer, resulting in the deregulation of intracellular signaling involving downstream non-receptor tyrosine kinases such as Src, and other Src-family kinases (SFKs), which act as central hubs to propagate deregulated and redundant upstream signals [88,89]. The gene discussed is SRC; the disease is cancer.